ロード中...
Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention
BACKGROUND: Reloading with high-dose atorvastatin shortly before percutaneous coronary interventions (PCIs) has been proposed as a strategy to reduce periprocedural myonecrosis. There has been a concern that statins that are metabolized by cytochrome P450 3A4 may interfere with clopidogrel metabolis...
保存先:
| 出版年: | Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4902146/ https://ncbi.nlm.nih.gov/pubmed/27350760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S98790 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|